XBP-1 deficiency in the nervous system protects against amyotrophic lateral sclerosis by increasing autophagy

  1. Claudio Hetz1,2,8,
  2. Peter Thielen2,
  3. Soledad Matus1,
  4. Melissa Nassif1,
  5. Felipe Court3,
  6. Roberta Kiffin4,
  7. Gabriela Martinez1,
  8. Ana María Cuervo4,
  9. Robert H. Brown5 and
  10. Laurie H. Glimcher2,6,7
  1. 1Institute of Biomedical Sciences, The FONDAP Center for Molecular Studies of the Cell (CEMC) and the Millennium Nucleus for Neural Morphogenesis (NEMO), University of Chile, Santiago, Chile;
  2. 2Department of Immunology and Infectious diseases, Harvard School of Public Health, Boston Massachusetts 02115, USA;
  3. 3Department of Physiology, Faculty of Biological Science, Pontifical Catholic University of Chile, Santiago, Chile;
  4. 4Institute for Aging Studies, Albert Einstein College of Medicine, Bronx, New York 10461,USA;
  5. 5MassGeneral Institute for Neurodegenerative Disease, Day Neuromuscular Research Laboratory, Massachusetts General Hospital, Charlestown, Massachusetts 02129, USA;
  6. 6Department of Medicine, Harvard Medical School, Boston, Massachusetts 02115, USA

    Abstract

    Mutations in superoxide dismutase-1 (SOD1) cause familial amyotrophic lateral sclerosis (fALS). Recent evidence implicates adaptive responses to endoplasmic reticulum (ER) stress in the disease process via a pathway known as the unfolded protein response (UPR). Here, we investigated the contribution to fALS of X-box-binding protein-1 (XBP-1), a key UPR transcription factor that regulates genes involved in protein folding and quality control. Despite expectations that XBP-1 deficiency would enhance the pathogenesis of mutant SOD1, we observed a dramatic decrease in its toxicity due to an enhanced clearance of mutant SOD1 aggregates by macroautophagy, a cellular pathway involved in lysosome-mediated protein degradation. To validate these observations in vivo, we generated mutant SOD1 transgenic mice with specific deletion of XBP-1 in the nervous system. XBP-1-deficient mice were more resistant to developing disease, correlating with increased levels of autophagy in motoneurons and reduced accumulation of mutant SOD1 aggregates in the spinal cord. Post-mortem spinal cord samples from patients with sporadic ALS and fALS displayed a marked activation of both the UPR and autophagy. Our results reveal a new function of XBP-1 in the control of autophagy and indicate critical cross-talk between these two signaling pathways that can provide protection against neurodegeneration.

    Keywords

    Footnotes

    Related Article

    | Table of Contents

    Life Science Alliance